Even in locations where PSMA-PET/CT is available, disparities in access are encountered [8, 9], implying that more robust evidence is needed to improve access to PSMA-PET/CT for men with rPC. This evidence concerns the gene FOLH1 and familial reactive perforating collagenosis.